Home » Archive

Articles in the Treatments Category

Resources, Treatments »

[Oct 15, 2008 8:00 am | One Comment]
Revlimid Lenalidomide (initially known as CC-5013 and marketed as Revlimid by Celgene) is a derivative of thalidomide introduced in 2004. It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic modality, but has also shown efficacy in the hematological disorders known as the myelodysplastic syndromes. [...]

Resources, Treatments »

[Oct 15, 2008 8:00 am | Comments Off]
Thalidomide Thalidomide is a sedative-hypnotic, and multiple myeloma medication. The drug is a potent teratogen in rats, rabbits, and primates including humans: this means that severe birth defects may result if the drug is taken during pregnancy. [...]

Resources, Treatments »

[Oct 15, 2008 8:00 am | One Comment]
Velcade Bortezomib (originally PS-341 and marketed as Velcade by Millennium Pharmaceuticals) is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease. [...]